GLYCOMINDS
Glycominds, a molecular diagnostics company, develops and commercializes autoimmune and chronic inflammatory disease management tools and services with a distinctive focus on the Multiple Sclerosis market. Their proprietary tests allow physicians to help identify patients at a higher risk for more severe disease outcomes.
GLYCOMINDS
Industry:
Biotechnology Health Diagnostics
Founded:
1999-01-01
Address:
Lod, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.glycominds.com
Total Employee:
11+
Status:
Closed
Total Funding:
1000 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business Google Google Cloud Sectigo SSL Sectigo Domain SSL
Current Employees Featured
![]()
Investors List
![]()
BRM Capital
BRM Capital investment in Venture Round - Glycominds
![]()
Millennium II Materials Technology Fund
Millennium II Materials Technology Fund investment in Venture Round - Glycominds
Official Site Inspections
http://www.glycominds.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
Loading ... 
